<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>work reintegration post-COVID &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/work-reintegration-post-covid/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 12:33:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>work reintegration post-COVID &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Research Reveals Significant Recovery in Long COVID Symptoms and Work Reintegration</title>
		<link>https://bioengineer.org/research-reveals-significant-recovery-in-long-covid-symptoms-and-work-reintegration/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 May 2025 15:13:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[BrainHQ cognitive training]]></category>
		<category><![CDATA[Long COVID recovery]]></category>
		<category><![CDATA[neuroplasticity-based interventions]]></category>
		<category><![CDATA[randomized controlled trial]]></category>
		<category><![CDATA[work reintegration post-COVID]]></category>
		<guid isPermaLink="false">https://bioengineer.org/research-reveals-significant-recovery-in-long-covid-symptoms-and-work-reintegration/</guid>

					<description><![CDATA[San Francisco, May 5, 2025 — In a groundbreaking advancement poised to redefine treatment paradigms for Long COVID, researchers at the University of Alabama at Birmingham (UAB) have conducted what is believed to be the first randomized controlled trial revealing substantial, even transformative improvements in the complex constellation of symptoms plaguing Long COVID sufferers. Long [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">243648</post-id>	</item>
	</channel>
</rss>
